Advertisement

Barriers to Implementing Cardiovascular Risk Calculation in Primary Care: Alignment With the Consolidated Framework for Implementation Research

Published:December 03, 2020DOI:https://doi.org/10.1016/j.amepre.2020.07.027

      Introduction

      Cardiovascular disease risk calculators can inform and guide preventive strategies and treatment decisions by clinicians and patients. However, their uptake in primary care has been slow despite the recommendation in national cardiovascular disease prevention guidelines. Identifying the barriers to the implementation of cardiovascular disease risk calculators is essential for promoting their adoption.

      Methods

      The authors qualitatively analyzed structured physician educator notes written during an outreach education intervention with 44 small- and medium-sized primary care clinics that participated in the Agency for Healthcare Research and Quality‒funded EvidenceNOW Healthy Hearts Northwest trial. The authors coded barriers to the implementation of cardiovascular disease risk calculation and aligned them to the Consolidated Framework for Implementation Research.

      Results

      The authors identified 13 barriers from the physician educators’ notes. The majority (n=8, 62%) mapped to the framework's Inner Setting domain. The 5 most commonly noted barriers were (1) time constraints to use a calculator (N=23 clinics), (2) limitations to accessing a calculator or the necessary information to use a calculator (N=22 clinics), (3) no or minimal buy-in from clinicians or staff to use a calculator (N=19 clinics), (4) reported patient fear of side effects from statin medications or patient dislike of taking medications per the guidelines (N=17 clinics), and (5) lack of documented clinic workflow for using a calculator (N=16 clinics).

      Conclusions

      To improve the uptake of cardiovascular disease risk calculation in primary care, future cardiovascular disease prevention and implementation research should consider tailoring interventions to the common barriers to implementing cardiovascular disease risk calculation.

      Trial registration

      This study is registered at www.clinicaltrials.gov NCT02839382.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

      1. Murphy SL, Kochanek KD, Xu J, Arias E. NCHS data brief no. 229: mortality in the United States, 2014. HHS, Centers for Disease Control and Prevention, National Center for Health Statistic.https://www.cdc.gov/nchs/data/databriefs/db229.pdf. Published December 2015. Accessed May 24, 2020.

        • Kottke TE
        • Faith DA
        • Jordan CO
        • Pronk NP
        • Thomas RJ
        • Capewell S
        The comparative effectiveness of heart disease prevention and treatment strategies.
        Am J Prev Med. 2009; 36: 82-88
        • Goff Jr, DC
        • Lloyd-Jones DM
        • Bennett G
        • et al.
        2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014;129(25)(suppl 2):S74-5].
        Circulation. 2014; 129: S49-S73
        • Goff Jr, DC
        • Lloyd-Jones DM
        • Bennett G
        • et al.
        2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in J Am Coll Cardiol. 2014;63(25 Pt B):3026].
        J Am Coll Cardiol. 2014; 63: 2935-2959
        • Bibbins-Domingo K
        • Grossman DC
        • et al.
        • U.S. Preventive Services Task Force
        Statin use for the primary prevention of cardiovascular disease in adults: U.S. Preventive Services Task Force recommendation statement [published correction appears in JAMA. 2020;323(7):669–670].
        JAMA. 2016; 316: 1997-2007
        • Chan WV
        • Pearson TA
        • Bennett GC
        • et al.
        ACC/AHA special report: clinical practice guideline implementation strategies: a summary of systematic reviews by the NHLBI Implementation Science Work Group: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
        J Am Coll Cardiol. 2017; 69: 1076-1092
        • Shillinglaw B
        • Viera AJ
        • Edwards T
        • Simpson R
        • Sheridan SL
        Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians.
        BMC Health Serv Res. 2012; 12: 20
      2. Sussman JB, Holleman RG, Youles B, Lowery JC. Quality improvement and personalization for statins: the QUIPS quality improvement randomized trial of veterans' primary care statin use [published correction appears in J Gen Intern Med. 2020. Jan 2, https://doi.org/10.1007/s11606-019-05597-0]. J Gen Intern Med. 2018;33(12):2132–2137. https://doi.org/10.1007/s11606-018-4681-6.

        • Lewis CC
        • Scott K
        • Marriott BR
        A methodology for generating a tailored implementation blueprint: an exemplar from a youth residential setting.
        Implement Sci. 2018; 13: 68
        • Flottorp SA
        • Oxman AD
        • Krause J
        • et al.
        A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice.
        Implement Sci. 2013; 8: 35
        • Karmali KN
        • Lloyd-Jones DM
        Implementing cardiovascular risk prediction in clinical practice: the future is now.
        J Am Heart Assoc. 2017; 6e006019
        • Bonner C
        • Fajardo MA
        • Doust J
        • McCaffery K
        • Trevena L
        Implementing cardiovascular disease prevention guidelines to translate evidence-based medicine and shared decision making into general practice: theory-based intervention development, qualitative piloting and quantitative feasibility.
        Implement Sci. 2019; 14: 86
        • Landon BE
        • Normand SL
        Performance measurement in the small office practice: challenges and potential solutions.
        Ann Intern Med. 2008; 148: 353-357
        • Shoemaker SJ
        • McNellis RJ
        • DeWalt DA
        The capacity of primary care for improving evidence-based care: early findings from AHRQ's EvidenceNOW.
        Ann Fam Med. 2018; 16: S2-S4
        • Cohen DJ
        • Balasubramanian BA
        • Gordon L
        • et al.
        A national evaluation of a dissemination and implementation initiative to enhance primary care practice capacity and improve cardiovascular disease care: the ESCALATES study protocol.
        Implement Sci. 2016; 11: 86
        • Meyers D
        • Miller T
        • Genevro J
        • et al.
        EvidenceNOW: balancing primary care implementation and implementation research.
        Ann Fam Med. 2018; 16: S5-S11
        • Parchman ML
        • Anderson ML
        • Dorr DA
        • et al.
        A randomized trial of external practice support to improve cardiovascular risk factors in primary care.
        Ann Fam Med. 2019; 17: S40-S49
        • Parchman ML
        • Fagnan LJ
        • Dorr DA
        • et al.
        Study protocol for “Healthy Hearts Northwest”: a 2 × 2 randomized factorial trial to build quality improvement capacity in primary care.
        Implement Sci. 2016; 11: 138
        • Soumerai SB
        • Avorn J
        Principles of educational outreach (‘academic detailing’) to improve clinical decision making.
        JAMA. 1990; 263: 549-556
      3. NaRCAD. https://www.narcad.org/. Accessed May 24, 2020.

        • Avorn J
        • Soumerai SB
        Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based detailing.
        N Engl J Med. 1983; 308: 1457-1463
        • Avorn J
        • Soumerai SB
        • Everitt DE
        • et al.
        A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes.
        N Engl J Med. 1992; 327: 168-173
        • Damschroder LJ
        • Aron DC
        • Keith RE
        • Kirsh SR
        • Alexander JA
        • Lowery JC
        Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science.
        Implement Sci. 2009; 4: 50
        • Waltz TJ
        • Powell BJ
        • Fernández ME
        • Abadie B
        • Damschroder LJ
        Choosing implementation strategies to address contextual barriers: diversity in recommendations and future directions.
        Implement Sci. 2019; 14: 42
        • Crabtree BF
        • Miller WL
        Immersion/crystallization.
        in: Crabtree BF Miller WL Doing Qualitative Research. Sage Publications, Thousand Oaks, CA1999: 163-177
        • Nutting PA
        • Crabtree BF
        • McDaniel RR
        Small primary care practices face four hurdles–including a physician-centric mind-set–in becoming medical homes.
        Health Aff (Millwood). 2012; 31: 2417-2422
      4. Taylor EF, Peikes D, Genevro J, Meyers D. Creating capacity for improvement in primary care: the case for developing a quality improvement infrastructure. Agency for Healthcare Research and Quality, Rockville, MD. https://www.ahrq.gov/ncepcr/tools/capacity/brief1.html. Updated April 2013. Accessed May 24, 2020.

        • Powell BJ
        • Beidas RS
        • Lewis CC
        • et al.
        Methods to improve the selection and tailoring of implementation strategies.
        J Behav Health Serv Res. 2017; 44: 177-194
        • Pronovost PJ
        Enhancing physicians’ use of clinical guidelines.
        JAMA. 2013; 310: 2501-2502